Anesthesia
Conditions
Keywords
Closed-loop Anesthesia, PID Control, Medical Control Systems, Automated Drug Delivery, Propofol, Remifentanil, Bispectral index, BIS
Brief summary
This study concerns the clinical evaluation of a closed loop control system for the automatic administration of anesthetic drugs in TIVA (Total Intra Venous Anesthesia). The purpose of the experimentation is to demonstrate that the control system under study is reliable, safe, applicable and capable of inducing and maintaining an optimal anesthetic level.
Detailed description
This clinical study consists of the application of the ACTIVA control software for the infusion of intravenous drugs during general anesthesia according to the principle of closed-loop anesthesia. The objective of the experimentation is to evaluate the reliability, safety and applicability of the infusion system for anesthetic drugs controlled by the ACTIVA software and to carry out the clinical evaluation of the automatic control system during the induction and maintenance of general intravenous anesthesia. The benefits for enrolled patients could be linked to greater stability of anesthesia in the induction and maintenance phases. Constant closed-loop control of infusions and the level of hypnosis could also reduce the hemodynamic impact that general anesthesia has on the patient, by reducing the onset of hypotension episodes. Enrolled patients will undergo closed-loop anesthesia under the constant supervision of the investigator. The anesthetic drugs used are those recommended for general intravenous anesthesia: propofol and remifentanil. Identification and description of the medical device: The medical device object of the clinical investigation consists of the ACTIVA control software developed to control the infusion of anesthetic drugs during general intravenous anesthesia. ACTIVA software has been developed to optimize the infusion of anesthetic drugs according to a closed-loop system that allows the induction and maintenance of a constant and optimal level of anesthesia on the patient. ACTIVA control software is installed on a personal computer (PC). The level of anesthesia is measured according to the Bispectral Index (BIS) which measures the depth of hypnosis. Through the measurement of the BIS, the administration of anesthetic drugs is automatically regulated by the ACTIVA software and constantly supervised by the anesthesiologist through the graphic interface integrated in the software. The population for which the device is intended is made up of patients to undergo surgery for which general anesthesia is required, and intravenous anesthesia may be advantageous. During its operation, the ACTIVA software maintains the desired BIS level, selected by the anesthesiologist through the graphical user interface, communicating the appropriate infusion rate of the propofol and remifentanil anesthetic drugs to the syringe pumps. ACTIVA software communicates with the pumps and the BIS monitoring system with serial connections. These connections are native to the instrumentation used; therefore, no type of modification or manipulation has been made on the medical devices used. Closed-loop anesthesia: A closed-loop system can be defined as an automatic control system that bases its operation on the principle of feedback. Its key elements are a system to be controlled, a measuring device (sensor), a controller and an actuator. The sensor measures the controlled variable (system output), which is compared with the desired set-point. The difference between the latter and the output, defined as an error, is used to calculate the value of the control variable (system input). In the case of closed-loop anesthesia, the system to be controlled identifies with the patient, the actuator is represented by the syringe pump, the controlled variable corresponds to the BIS and the control variable is represented by the rate of infusion of the drugs. The controller used is a proportional-integral-derivative (PID) it relates the error signal and the control variable by means of three constants (Kp, Ti and Td) allowing a correct infusion of the drugs considering the present value of the error ( proportional action), the past values of the error (integral action) and the advance of the future values of the error (derivative action). These three constants, if properly calibrated, allow to obtain a controller with good performance and robustness. For the ACTIVA system the calibration of these constants was carried out by means of optimization methods performed in simulation. The anesthesiologist has at his disposal a PC with a graphical user interface through which he can control the start and end of the drug infusion and on which there are the commands through which it is possible to interact with the system. The graphical interface also reports indicators concerning the correct functioning of the control system. In case of malfunction of the ACTIVA software, the patient monitoring systems are never altered or damaged and the infusive pumps continue to operate in manual mode. Switching to manual control is always possible if the anesthesiologist considers it appropriate, even without the presence of system malfunctions.
Interventions
Total intravenous anesthesia performed with the ACTIVA automatic control system
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients undergoing total intravenous general anesthesia for elective surgery
Exclusion criteria
* Patients under the age of 18 * Patients incapable of giving consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Depth of Hypnosis Adequacy | During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours. | The depth of hypnosis adequacy is assessed by evaluating, for each patient enrolled, the percentage of maintenance duration during which the Bispectral Index Scale (BIS) is kept within the recommended range from 40 to 60 (BIS \[40,60\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the BIS is kept below 40 (BIS\<40) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. The BIS ranges from 0 (absence of brain activity) to 100 (fully awake patient). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours. | Levels of satisfaction of the experimenter regarding three aspects of the ACTIVA system. The first aspect is the ease of use of the ACTIVA software and its infusion system. The second aspect is the behavior of the ACTIVA system during the induction phase of anesthesia. The third aspect is the behavior of the ACTIVA system during the maintenance phase of anesthesia. For each aspect, the level of satisfaction is expressed by the experimenter by assigning a score on a scale ranging from 0 (extremely unsatisfied) to 10 (extremely satisfied). Thus, higher values represent a better outcome. Note that the scoring scale employed is the same for each of the three aspects. The results are reported in a table divided in three rows, one for each aspect evaluated. Each row is divided in eleven categories representing the scores from 0 to 10. For each category it is indicated the number of patients for which the experimenter expressed that specific score. |
| Effect of Drugs Delivery on Heart Rate | During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours. | The effect of drugs delivery on heart rate is assessed by evaluating, for each patient enrolled, the percentage of the anesthesia maintenance duration in which the heart rate (HR) is kept inside the range from 50 to 100 beats per minute (HR \[50,100\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the HR is kept below 50 (HR\<50) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. |
| Effect of Drugs Delivery on Mean Arterial Pressure (MAP) | During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours. | The effect of drugs delivery on mean arterial pressure (MAP) is assessed by evaluating, for each patient enrolled, the anesthesia maintenance duration in which the non-invasively measured MAP is kept inside the range from 65 to 110 mmHg (MAP \[65,110\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the MAP is kept below 65 (MAP\<65) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. MAP is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure). |
| Postoperative Heart Rate Stability | End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery. | The postoperative heart rate is assessed by measuring the heart rate in beats per minute (bpm). |
| Number of Participants for Which the System Showed Dysfunctions | During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours. | Number of participants for which the ACTIVA system showed dysfunctions. The results are presented in a table where each row indicates the type of dysfunction and the number of participants for which that particular type of dysfunction occurred. |
| Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery. | The postoperative sedation is assessed by means of a Sedation Score scale. It is a 3 point scale from 0 (fully awake) to 3 (fully sedated) |
| Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery. | Postoperative Nausea and Vomiting is assessed by means of the Bellville PONV scale. It is a 3 point scale from 0 (no nausea & vomiting) to 3 (vomiting present) |
| Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery. | The postoperative analgesia is assessed using a 10-point numeric rating scale (NRS). It is a 10 point scale from 0 (no pain) to 10 (maximum pain). |
| Postoperative Mean Arterial Pressure (MAP) Stability | End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery. | The postoperative mean arterial pressure (MAP) stability is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer trough an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure). |
Countries
Italy
Participant flow
Recruitment details
The recruited patients were patients scheduled for elective plastic surgery for whom general anesthesia performed in TIVA was deemed appropriate. The recruitments took place at the Spedali Civili di Brescia hospital, in the plastic surgery operating room. The first participant was enrolled on July 2, 2019 and the last participant was enrolled on April 4, 2023.
Pre-assignment details
Patients were approached and informed of the possibility to participate in the study during the preoperative anesthesia visit, which takes place two weeks before the scheduled surgical procedure. If the patient wishes to participate in the study, the informed consent is obtained on the day of surgery, at the patient's arrival in the preoperative holding area.
Participants by arm
| Arm | Count |
|---|---|
| ACTIVA Participants received total intravenous anesthesia performed with the ACTIVA automatic control system. | 139 |
| Total | 139 |
Baseline characteristics
| Characteristic | ACTIVA | — |
|---|---|---|
| Age, Continuous | 57 years | — |
| ASA status ASA 1 | 12 Participants | — |
| ASA status ASA 2 | 96 Participants | — |
| ASA status ASA 3 | 31 Participants | — |
| Heart rate | 71 beats per minute | — |
| Height | 165 cm | — |
| Mean arterial pressure | 100 mmHg | — |
| PONV risk 0 | 8 Participants | — |
| PONV risk 1 | 34 Participants | — |
| PONV risk 2 | 39 Participants | — |
| PONV risk 3 | 45 Participants | — |
| PONV risk 4 | 13 Participants | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Region of Enrollment Italy | 139 Participants | — |
| Sex: Female, Male Female | 98 Participants | — |
| Sex: Female, Male Male | 41 Participants | — |
| Type of surgery Brachioplasty | 1 Participants | — |
| Type of surgery Electrochemotherapy | 7 Participants | — |
| Type of surgery Eyelid surgery | 2 Participants | — |
| Type of surgery Lipofilling | 5 Participants | — |
| Type of surgery Mastectomy | 34 Participants | — |
| Type of surgery Mastoplasty | 28 Participants | — |
| Type of surgery Rhinoplasty | 1 Participants | — |
| Type of surgery Skin cancer exeresis | 54 Participants | — |
| Type of surgery Surgical treatment of wounds | 7 Participants | — |
| Weight | 70 kg | — |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 139 |
| other Total, other adverse events | 0 / 139 |
| serious Total, serious adverse events | 0 / 139 |
Outcome results
Depth of Hypnosis Adequacy
The depth of hypnosis adequacy is assessed by evaluating, for each patient enrolled, the percentage of maintenance duration during which the Bispectral Index Scale (BIS) is kept within the recommended range from 40 to 60 (BIS \[40,60\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the BIS is kept below 40 (BIS\<40) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. The BIS ranges from 0 (absence of brain activity) to 100 (fully awake patient).
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| ACTIVA | Depth of Hypnosis Adequacy | BIS [40,60] | 79.4 percentage of maintenance duration |
| ACTIVA | Depth of Hypnosis Adequacy | BIS<40 | 16.2 percentage of maintenance duration |
Effect of Drugs Delivery on Heart Rate
The effect of drugs delivery on heart rate is assessed by evaluating, for each patient enrolled, the percentage of the anesthesia maintenance duration in which the heart rate (HR) is kept inside the range from 50 to 100 beats per minute (HR \[50,100\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the HR is kept below 50 (HR\<50) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| ACTIVA | Effect of Drugs Delivery on Heart Rate | HR<50 | 0.3 percentage of maintanance duration |
| ACTIVA | Effect of Drugs Delivery on Heart Rate | HR [50,100] | 99.7 percentage of maintanance duration |
Effect of Drugs Delivery on Mean Arterial Pressure (MAP)
The effect of drugs delivery on mean arterial pressure (MAP) is assessed by evaluating, for each patient enrolled, the anesthesia maintenance duration in which the non-invasively measured MAP is kept inside the range from 65 to 110 mmHg (MAP \[65,110\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the MAP is kept below 65 (MAP\<65) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. MAP is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| ACTIVA | Effect of Drugs Delivery on Mean Arterial Pressure (MAP) | MAP [65,110] | 79.0 percentage of maintenance duration |
| ACTIVA | Effect of Drugs Delivery on Mean Arterial Pressure (MAP) | MAP<65 | 15.7 percentage of maintenance duration |
Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score
Levels of satisfaction of the experimenter regarding three aspects of the ACTIVA system. The first aspect is the ease of use of the ACTIVA software and its infusion system. The second aspect is the behavior of the ACTIVA system during the induction phase of anesthesia. The third aspect is the behavior of the ACTIVA system during the maintenance phase of anesthesia. For each aspect, the level of satisfaction is expressed by the experimenter by assigning a score on a scale ranging from 0 (extremely unsatisfied) to 10 (extremely satisfied). Thus, higher values represent a better outcome. Note that the scoring scale employed is the same for each of the three aspects. The results are reported in a table divided in three rows, one for each aspect evaluated. Each row is divided in eleven categories representing the scores from 0 to 10. For each category it is indicated the number of patients for which the experimenter expressed that specific score.
Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 0 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 1 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 2 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 4 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 5 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 7 | 23 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 8 | 56 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 9 | 42 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 0 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 1 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 2 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 6 | 7 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 7 | 14 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 8 | 35 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 9 | 53 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 10 | 30 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 0 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 1 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 2 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 3 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 4 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 5 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 6 | 10 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 9 | 48 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 10 | 33 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 3 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 6 | 6 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | General level of satisfaction | 10 | 12 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 3 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 4 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia induction | 5 | 0 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 7 | 16 Participants |
| ACTIVA | Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score | Level of satisfaction regarding anesthesia maintenance | 8 | 32 Participants |
Number of Participants for Which the System Showed Dysfunctions
Number of participants for which the ACTIVA system showed dysfunctions. The results are presented in a table where each row indicates the type of dysfunction and the number of participants for which that particular type of dysfunction occurred.
Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| ACTIVA | Number of Participants for Which the System Showed Dysfunctions | Venous access occlusion | 8 Participants |
| ACTIVA | Number of Participants for Which the System Showed Dysfunctions | Infusion pumps failure | 8 Participants |
| ACTIVA | Number of Participants for Which the System Showed Dysfunctions | No system dysfunctions | 123 Participants |
Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score
The postoperative analgesia is assessed using a 10-point numeric rating scale (NRS). It is a 10 point scale from 0 (no pain) to 10 (maximum pain).
Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 0 | 92 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 1 | 4 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 2 | 7 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 3 | 6 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 4 | 13 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 5 | 6 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 6 | 3 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 7 | 5 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 8 | 2 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 9 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 10 | 1 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 0 | 74 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 1 | 6 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 2 | 16 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 3 | 18 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 4 | 7 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 5 | 6 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 6 | 5 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 7 | 6 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 8 | 1 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 9 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 0 | 71 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 1 | 12 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 2 | 17 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 5 | 4 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 6 | 3 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 7 | 2 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 8 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 9 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 10 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 0 | 88 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 1 | 18 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 2 | 12 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 3 | 9 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 4 | 7 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 5 | 4 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 6 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 7 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 8 | 1 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 9 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 10 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 10 | 0 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 3 | 18 Participants |
| ACTIVA | Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 4 | 12 Participants |
Postoperative Heart Rate Stability
The postoperative heart rate is assessed by measuring the heart rate in beats per minute (bpm).
Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| ACTIVA | Postoperative Heart Rate Stability | Operating room discharge | 72 beats per minute |
| ACTIVA | Postoperative Heart Rate Stability | Recovery room admission | 74 beats per minute |
| ACTIVA | Postoperative Heart Rate Stability | Recovery room discharge | 74 beats per minute |
| ACTIVA | Postoperative Heart Rate Stability | 6 hours after surgery | 74 beats per minute |
| ACTIVA | Postoperative Heart Rate Stability | 24 hours after surgery | 72 beats per minute |
Postoperative Mean Arterial Pressure (MAP) Stability
The postoperative mean arterial pressure (MAP) stability is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer trough an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).
Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| ACTIVA | Postoperative Mean Arterial Pressure (MAP) Stability | Operating room discharge | 82 mmHg |
| ACTIVA | Postoperative Mean Arterial Pressure (MAP) Stability | Recovery room admission | 83 mmHg |
| ACTIVA | Postoperative Mean Arterial Pressure (MAP) Stability | Recovery room discharge | 85 mmHg |
| ACTIVA | Postoperative Mean Arterial Pressure (MAP) Stability | 6 hours after surgery | 90 mmHg |
| ACTIVA | Postoperative Mean Arterial Pressure (MAP) Stability | 24 hours after surgery | 88 mmHg |
Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score
Postoperative Nausea and Vomiting is assessed by means of the Bellville PONV scale. It is a 3 point scale from 0 (no nausea & vomiting) to 3 (vomiting present)
Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 0 | 136 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 1 | 3 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 2 | 0 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 3 | 0 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 0 | 133 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 1 | 4 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 2 | 1 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 3 | 1 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 0 | 135 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 1 | 4 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 2 | 0 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 3 | 0 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 0 | 136 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 1 | 2 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 2 | 0 Participants |
| ACTIVA | Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 3 | 1 Participants |
Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score
The postoperative sedation is assessed by means of a Sedation Score scale. It is a 3 point scale from 0 (fully awake) to 3 (fully sedated)
Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 0 | 97 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 1 | 40 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 2 | 2 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room admission | 3 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 1 | 24 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 2 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 3 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 0 | 135 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 1 | 4 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 2 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 6 hours after surgery | 3 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 0 | 139 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 1 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 2 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | 24 hours after surgery | 3 | 0 Participants |
| ACTIVA | Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score | Recovery room discharge | 0 | 115 Participants |
Extubation Time
The extubation time is the time interval that elapses from the time instant when the automatic control is stopped to when the patient is extubated. It is an indicator of the awakening time.
Time frame: During anesthesia from the time instant when the automatic control is stopped to when the patient is extubated, up to 11 minutes.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Extubation Time | 496 seconds |
Global Score (GS)
The Global Score (GS) is a performance index that characterize the overall control performance. It is calculated as (MDAPE+WOBBLE)/BIS \[40,60\]. For each patient (i) and for each Bispectral Index Scale (BIS) sample (j): PEij=((BISij BIS\_Target)/BIS\_Target)\*100, with BIS\_Target=50. MDAPEi=median{\|PEij\|}. WOBBLEi=median{\|PEij-MDPEi\|}. BIS \[40,60\] is the percentage of the anesthesia maintenance duration in which the BIS is kept between 40 and 60. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction, defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, to the point at which the automatic control is turned off at the conclusion of surgery. The GS ranges from zero to infinity. The lower the GS, the better the control performance. Specifically, a GS value of zero would correspond to the case where the BIS is always maintained at its target value.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Global Score (GS) | 26.3 Dimensionless |
Induction Time
The induction time is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 110 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Induction Time | 103 seconds |
Lowest Bispectral Index (BIS) Induction
The lowest Bispectral Index (BIS) is the lowest BIS value observed within the 60 seconds following the induction time. The BIS quantifies the cerebral activity and ranges from 99 (corresponding to a fully awake and aware patient) to 0 (corresponding to the absence of brain activity. For general anesthesia it is recommended to keep the BIS inside the range 40-60. Values above 60 represent a too light anesthesia while values below 40 represents a too deep anesthesia.
Time frame: During anesthesia from the time instant when the automatic control is started to 60 seconds following the induction time, an average of 170 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Lowest Bispectral Index (BIS) Induction | 42 units on a scale (BIS) |
Lowest Heart Rate Induction
The lowest heart rate is the lowest heart rate value observed within the 5 minutes following the induction time.
Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Lowest Heart Rate Induction | 54 beats per minute |
Lowest Mean Arterial Pressure (MAP) Induction
The lowest mean arterial pressure (MAP) is the lowest value of the MAP observed within the 5 minutes following the induction time. It is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer embedded in a multiparametric patient monitor through an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).
Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Lowest Mean Arterial Pressure (MAP) Induction | 69 mmHg |
MDAPE
The MDAPE is the median absolute performance error calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij-BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The MDAPE is a measure of inaccuracy. The MDAPE is calculated according to the formula: MDAPEi=median{\|PEij\|}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | MDAPE | 12 percentage of target BIS value |
MDPE
The MDPE is the median performance error calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij-BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The MDPE is a measure of bias and describes whether the measured BIS values are systematically distributed either above or below the BIS target. The MDPE is calculated according to the formula: MDPEi=median{PEij}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | MDPE | -10 percentage of target BIS value |
Median Maintenance Propofol Effect-Site Concentration
It is the median propofol effect-site concentration achieved by the ACTIVA system during the maintenance phase of anesthesia. It is estimated according to the Schnider model. The outcome measure is defined as the median of the propofol effect-site concentrations achieved by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Median Maintenance Propofol Effect-Site Concentration | 2.72 ug/ml |
Median Maintenance Propofol Infusion Rate
It is the median value of the propofol infusion rate administered by the ACTIVA system during the maintenance phase of anesthesia. The outcome measure is defined as the median of the propofol infusion rates administered by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Median Maintenance Propofol Infusion Rate | 6.19 mg/kg/h |
Median Maintenance Remifentanil Effect-Site Concentration
It is the median remifentanil effect-site concentration achieved by the ACTIVA system during the maintenance phase of anesthesia. It is estimated according to the Minto model. The outcome measure is defined as the median of the remifentanil effect-site concentrations achieved by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Median Maintenance Remifentanil Effect-Site Concentration | 5.02 ng/ml |
Median Maintenance Remifentanil Infusion Rate
It is the median value of the remifentanil infusion rate administered by the ACTIVA system during the maintenance phase of anesthesia. The outcome measure is defined as the median of the remifentanil infusion rates administered by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Median Maintenance Remifentanil Infusion Rate | 0.16 ug/kg/min |
Number of Participants That Received Hemodynamic Interventions
Number of Participants that showed cases of hypotension treated with ephedrine or etilefrine before and after the beginning of the surgical stimulation (incision).
Time frame: During anesthesia from the time instant when the automatic control is started to incision for the cases before incision. During anesthesia from incision to the time instant when the automatic control is stopped for the cases after incision.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| ACTIVA | Number of Participants That Received Hemodynamic Interventions | Before incision | 26 Participants |
| ACTIVA | Number of Participants That Received Hemodynamic Interventions | After incision | 71 Participants |
Number of Participants With Burst-Suppression Episode During Anesthesia Maintenance
Number of Participants that showed the occurrence of a burst-suppression episode during the maintenance phase. A burst-suppression episode is defined as a value of burst-suppression ratio (BSR) above 10% for at least 60 seconds. The maintenance phase here is defined as the period of time that goes from the 5 minutes after the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| ACTIVA | Number of Participants With Burst-Suppression Episode During Anesthesia Maintenance | 25 Participants |
Number of Participants With Burst-Suppression Episode Following Anesthesia Induction
Number of Participants that showed the occurrence of a burst-suppression episode within the 5 minutes following the induction time. A burst-suppression episode is defined as a value of burst-suppression ratio (BSR) above 10% for at least 60 seconds.
Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| ACTIVA | Number of Participants With Burst-Suppression Episode Following Anesthesia Induction | 6 Participants |
Propofol Induction Dose
Propofol dose administered by the system throughout the induction time.
Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 170 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Propofol Induction Dose | 1.90 mg/kg |
Remifentanil Induction Dose
Remifentanil dose administered by the system throughout the induction time.
Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 170 seconds.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | Remifentanil Induction Dose | 2.16 ug/kg |
WOBBLE
The WOBBLE is an index of time-related changes in the performance and measures the intra-patient variability in performance errors. It is calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The WOBBLE is calculated according to the formula: WOBBLEi=median{\|PEij-MDPEi\|}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| ACTIVA | WOBBLE | 8 percentage of target BIS value |